Earnings
FSTX
10.14
+9.03%
0.84
Currencies: USD
Items
Net Income
Depreciation and Amortization
Deferred Tax
Unamortized Expenditures
Accrued Expenses
Share-based Compensation
Assets Disposal
Financial Expenses
Investment Loss
Working Capital Change
Other Items
Operating Activities
Purchases of Fixed Assets
Proceeds from Disposal of Fixed Assets
Investment Expenditure
Investment Income
Other Investing Activities
Investing Activities
Issuance of Capital Stock
Issuance of Bonds
Proceeds from Borrowings
Dividend Payments
Repayment of Borrowings
Buyback Payments
Stock Incentive Compensation
Other Financing Activities
Financing Activities
Effect of Exchange Rate Changes 
Net Increase in Cash,Cash Equivalents
FY 2020-12-31
-25.62M
1.14M
--
--
--
--
7.22M
--
--
1.03M
--
-16.23M
-730.00K
--
--
--
14.78M
14.05M
15.00M
850.00K
--
--
--
--
--
--
15.85M
-48.00K
13.63M
FY 2019-12-31
-24.10M
357.00K
--
--
--
--
-4.50M
--
--
-810.00K
--
-29.05M
-272.00K
--
--
--
23.77M
23.50M
6000.00
20.00M
--
--
--
--
--
--
19.54M
--
13.98M
FY 2018-12-31
-22.85M
288.00K
--
--
--
--
-1.45M
--
--
-1.23M
--
-25.24M
-1.97M
--
--
--
-23.13M
-25.10M
41.17M
--
--
--
--
--
--
--
41.17M
--
-9.18M
FY 2017-12-31
-27.68M
158.00K
--
--
--
--
8.66M
--
--
1.17M
--
-17.68M
-323.00K
--
--
--
-12.08M
-12.41M
43.54M
--
--
--
--
--
--
--
43.54M
--
13.45M
FY 2016-12-31
-17.37M
118.00K
--
--
--
--
2.31M
--
--
-877.00K
--
-15.82M
-213.00K
--
--
--
-6.29M
-6.51M
28.66M
--
--
--
--
--
--
--
28.66M
--
6.34M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out FSTX latest annual and quarterly financial reports. There are also historical financial reports for you to reference. You can analyze F-star Therapeutics Inc recent business situations by check its cash flow statements, balance sheets, income statements and other tables. Comprehensive data may help you to understand and analyze FSTX development prospects in various aspects, and this information may help you to better grasp the F-star Therapeutics Inc operation.